186 related articles for article (PubMed ID: 29992451)
1. Mucinous adenocarcinoma, gastric type of the uterine cervix: clinical features and HER2 amplification.
Nakamura A; Yamaguchi K; Minamiguchi S; Murakami R; Abiko K; Hamanishi J; Kondoh E; Baba T; Mandai M; Matsumura N
Med Mol Morphol; 2019 Mar; 52(1):52-59. PubMed ID: 29992451
[TBL] [Abstract][Full Text] [Related]
2. An analysis of HER2 amplification in cervical adenocarcinoma: correlation with clinical outcomes and the International Endocervical Adenocarcinoma Criteria and Classification.
Shi H; Shao Y; Lu W; Lu B
J Pathol Clin Res; 2021 Jan; 7(1):86-95. PubMed ID: 33089969
[TBL] [Abstract][Full Text] [Related]
3. Relationship between HER2 expression and tumor interstitial angiogenesis in primary gastric cancer and its effect on prognosis.
Li F; Meng G; Tan B; Chen Z; Ji Q; Wang X; Liu C; Niu S; Li Y; Liu Y
Pathol Res Pract; 2021 Jan; 217():153280. PubMed ID: 33253925
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive genomic profiling and prognostic analysis of cervical gastric-type mucinous adenocarcinoma.
Lu S; Shi J; Zhang X; Kong F; Liu L; Dong X; Wang K; Shen D
Virchows Arch; 2021 Nov; 479(5):893-903. PubMed ID: 33817764
[TBL] [Abstract][Full Text] [Related]
5. Comparison of intratumoral heterogeneity of HER2 expression between primary tumor and multiple organ metastases in gastric cancer: Clinicopathological study of three autopsy cases and one resected case.
Saito T; Kondo C; Shitara K; Ito Y; Saito N; Ikehara Y; Yatabe Y; Yamamichi K; Tanaka H; Nakanishi H
Pathol Int; 2015 Jun; 65(6):309-17. PubMed ID: 25828363
[TBL] [Abstract][Full Text] [Related]
6. Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix.
Kojima A; Mikami Y; Sudo T; Yamaguchi S; Kusanagi Y; Ito M; Nishimura R
Am J Surg Pathol; 2007 May; 31(5):664-72. PubMed ID: 17460448
[TBL] [Abstract][Full Text] [Related]
7. HER2 amplification and overexpression are significantly correlated in mucinous epithelial ovarian cancer.
Chao WR; Lee MY; Lin WL; Chen CK; Lin JC; Koo CL; Sheu GT; Han CP
Hum Pathol; 2014 Apr; 45(4):810-6. PubMed ID: 24656091
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use?
Park YS; Hwang HS; Park HJ; Ryu MH; Chang HM; Yook JH; Kim BS; Jang SJ; Kang YK
Hum Pathol; 2012 Mar; 43(3):413-22. PubMed ID: 21855114
[TBL] [Abstract][Full Text] [Related]
9. Consistent absence of HER2 expression, regardless of HER2 amplification status, in neuroendocrine carcinomas of the stomach.
Ishida M; Sekine S; Taniguchi H; Fukagawa T; Katai H; Kushima R
Histopathology; 2014 Jun; 64(7):1027-31. PubMed ID: 24329753
[TBL] [Abstract][Full Text] [Related]
10. A large cohort of consecutive patients confirmed frequent HER2 positivity in gastric carcinomas with advanced stages.
Cho J; Jeong J; Sung J; Sung CO; Kim KM; Park CK; Choi MG; Sohn TS; Bae JM; Kim S
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S477-84. PubMed ID: 23274580
[TBL] [Abstract][Full Text] [Related]
11. HER2/neu gene amplification and protein overexpression in gastric and gastroesophageal junction adenocarcinoma: a review of histopathology, diagnostic testing, and clinical implications.
Hechtman JF; Polydorides AD
Arch Pathol Lab Med; 2012 Jun; 136(6):691-7. PubMed ID: 22646280
[TBL] [Abstract][Full Text] [Related]
12. Metastatic adenocarcinoma to the uterine cervix from gastric cancer. A clinicopathologic analysis of 16 cases.
Imachi M; Tsukamoto N; Amagase H; Shigematsu T; Amada S; Nakano H
Cancer; 1993 Jun; 71(11):3472-7. PubMed ID: 8387879
[TBL] [Abstract][Full Text] [Related]
13. HER2 genomic heterogeneity is a frequent event in gastroesophageal adenocarcinoma and correlates with tumor morphology.
Machado-Neves R; Vale J; Eloy C; Polónia A
Pathol Res Pract; 2020 Sep; 216(9):153090. PubMed ID: 32825958
[TBL] [Abstract][Full Text] [Related]
14. Human epidermal growth factor receptor 2 amplification detection by droplet digital polymerase chain reaction in formalin-fixed paraffin-embedded breast and gastric cancer samples.
Wang X; Wu Y; Song X; Sun C; Wu C; Feng H
J Cancer Res Ther; 2017; 13(4):730-734. PubMed ID: 28901323
[TBL] [Abstract][Full Text] [Related]
15. Identification of the coexisting HER2 gene amplification and novel mutations in the HER2 protein-overexpressed mucinous epithelial ovarian cancer.
Lin WL; Kuo WH; Chen FL; Lee MY; Ruan A; Tyan YS; Hsu JD; Chiang H; Han CP
Ann Surg Oncol; 2011 Aug; 18(8):2388-94. PubMed ID: 21347793
[TBL] [Abstract][Full Text] [Related]
16. Re-evaluation of HER2 status in patients with HER2-positive advanced or recurrent gastric cancer refractory to trastuzumab (KSCC1604).
Saeki H; Oki E; Kashiwada T; Arigami T; Makiyama A; Iwatsuki M; Narita Y; Satake H; Matsuda Y; Sonoda H; Shimokawa M; Maehara Y;
Eur J Cancer; 2018 Dec; 105():41-49. PubMed ID: 30391779
[TBL] [Abstract][Full Text] [Related]
17. Primary endocervical gastric-type adenocarcinoma: a clinicopathologic and immunohistochemical analysis of 23 cases.
Lu S; Shen D; Zhao Y; Kang N; Wang X
Diagn Pathol; 2019 Jul; 14(1):72. PubMed ID: 31279344
[TBL] [Abstract][Full Text] [Related]
18. Stromal p16 Overexpression in Gastric-type Mucinous Carcinoma of the Uterine Cervix.
Chung T; DO SI; Na K; Kim G; Jeong YI; Kim YW; Kim HS
Anticancer Res; 2018 Jun; 38(6):3551-3558. PubMed ID: 29848709
[TBL] [Abstract][Full Text] [Related]
19. Mucinous gastric carcinomas: clinicopathologic and molecular analyses.
Choi JS; Kim MA; Lee HE; Lee HS; Kim WH
Cancer; 2009 Aug; 115(15):3581-90. PubMed ID: 19479974
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of the protein expression and gene amplification of HER2 in gastric cancer].
Liu JL; Li ZK; Xin FJ; Zhao H; Zhao W; Gao Y; Hu JL; Zhang XX; Zhang MS; Zhang BY; Lu Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):898-901. PubMed ID: 24062004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
